Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
about
Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicingGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceEngineering T Cells to Functionally Cure HIV-1 InfectionSurvival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infectionSelection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 proteinLong lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoyInhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant RevA role for KH domain proteins (Sam68-like mammalian proteins and quaking proteins) in the post-transcriptional regulation of HIV replication.Gene therapy for HIV.Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.Ongoing trials of immune-based therapies for HIV infection in adults.Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy.Genetic therapy for HIV/AIDS.Is gene therapy a good therapeutic approach for HIV-positive patients?Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individualsMultigene antiviral vectors inhibit diverse human immunodeficiency virus type 1 cladesIn vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat.Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection.Molding a peptide into an RNA site by in vivo peptide evolution.Genetic therapies against HIV.Novel cell and gene therapies for HIV.Practical considerations in gene therapy for HIV cure.Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs.Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector.A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replicationScaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells.Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes.Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection.RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replicationCell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory geneEffects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination.Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G.Mutational analysis of bovine leukemia virus Rex: identification of a dominant-negative inhibitorInhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides.Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
P2860
Q24652351-71C5A489-ACC5-4EFE-A73D-1C2485546EBCQ24671943-80520A95-0878-4AE6-9990-96D345BEC548Q27022347-72E0918D-D93F-4268-B84E-C31F789E5EA7Q28086801-44C1AA4A-7EC0-4254-A3DB-AC71430C93DDQ28749594-4E49B9ED-9961-4E95-8AE9-9CBF1D45E42EQ30304057-A413418A-B34C-4ABA-BB83-F9137A96C09AQ30373903-AD1FD447-EAA4-4FB1-A382-9731AABC04BFQ33784122-432D1618-D96F-43CF-8237-A73BFCAAB7C4Q33814620-707EC6D8-84FE-4AA8-8AAA-10ECC9E58C0CQ33851112-0A86F318-A4B2-4FBC-A484-B4B45A363FCFQ33956386-5B9E3AF8-31D4-41BC-B5A6-21CA2E98F5B3Q34208320-FB0ECF56-56C7-4BD9-9581-CAFA816B8483Q34353375-A0580282-D5DF-41C7-BFFA-B709C213184DQ34451967-52715FB9-8EE5-43DC-8795-3AE1225FD741Q35024116-2AB8C86D-AA5C-45C4-A384-1DAB2164E832Q35207524-C5C1300A-1FDF-4289-B364-8200C55D003EQ35663424-5AFF6893-26D4-4F17-9EBF-E003CDA8EC26Q35800195-AF29206C-B8EC-4FE3-B37B-7C8D3A1F5748Q35881105-1B86726F-9865-4A2F-B585-6344E9AAD80DQ36228890-CCA79F25-F87A-4B73-AF9E-46277D8F6D2FQ36602638-02221141-6980-46D0-9B67-D4EA75746A44Q36625534-945A8BC4-88D3-4121-B154-D01AE8916753Q37027170-87430D16-E305-457B-8124-9CE318BE781AQ38048762-C9CA3199-03DE-4C21-8766-0955B345E868Q38180645-A8D0CBD7-CEC7-461E-A958-513ABA290871Q38462651-E52C9A65-0F24-4DBD-B43B-5DCBEF2D0312Q38723282-2019AEB9-B1F3-42A7-BCF2-5FB1C2C51EC4Q39214476-9927F7AF-12FD-47B0-B80F-40306C1B33C3Q39577700-A67EDDC7-5826-4241-8A9C-C8DA7F8BC156Q39578259-2848058B-5B3C-4ED1-9693-F35FF6318D64Q39683830-113F111A-BDC9-457A-BEB8-7CE099AA1C17Q39877337-A1EB736E-A99D-438F-AAE7-B341D1E953A1Q39878947-35BFAA62-62AD-45B6-B840-5A8FD30F1998Q39879985-16CBEDF1-46A9-4AD5-ADB9-A5A56C216EE8Q39881018-3E68FBE7-77C0-4DF7-A57F-98835D530C21Q40084435-F74F97BC-DC02-4327-A392-51D7847E6B53Q40237715-63A74B75-1C2B-4E78-82B5-0D1C8F712A41Q40423196-CF341FCF-E899-40A3-8DF0-D4E5EAF88817Q40604434-20AE36F9-C38C-4877-A571-67FE9CAD8924Q40739621-A2D96D94-B8BB-4839-9A5D-799F77EFD1C0
P2860
Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of a protective gen ...... iency virus-infected patients.
@en
Expression of a protective gen ...... iency virus-infected patients.
@nl
type
label
Expression of a protective gen ...... iency virus-infected patients.
@en
Expression of a protective gen ...... iency virus-infected patients.
@nl
prefLabel
Expression of a protective gen ...... iency virus-infected patients.
@en
Expression of a protective gen ...... iency virus-infected patients.
@nl
P2093
P2860
P356
P1476
Expression of a protective gen ...... iency virus-infected patients.
@en
P2093
P2860
P304
P356
10.1073/PNAS.93.7.2889
P407
P577
1996-04-01T00:00:00Z